135
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Mepolizumab
Mepolizumab is a fully humanised Immunoglobulin G antibody (IgG1, kappa) with human heavy and light chain frameworks.
Placebo
Will be available as an equivalent volume of 0.9% sodium chloride.
OCS (prednisone/prednisolone)
Oral Corticosteroid (prednisone/prednisolone)
GSK Investigational Site, New Lambton
GSK Investigational Site, Parkville
GSK Investigational Site, Bedford Park
GSK Investigational Site, Nedlands
GSK Investigational Site, Potsdam
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Lübeck
GSK Investigational Site, Spartanburg
GSK Investigational Site, Hanover
GSK Investigational Site, Montpellier
GSK Investigational Site, Gières
GSK Investigational Site, Nantes
GSK Investigational Site, Guadalajara
GSK Investigational Site, Zapopan
GSK Investigational Site, Cincinnati
GSK Investigational Site, Mainz
GSK Investigational Site, Rochester
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, St Louis
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Gelnhausen
GSK Investigational Site, Aschaffenburg
GSK Investigational Site, Strasbourg
GSK Investigational Site, Paris
GSK Investigational Site, Denver
GSK Investigational Site, Long Beach
GSK Investigational Site, New Haven
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Hamilton
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Brno
GSK Investigational Site, Olomouc
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Amsterdam
GSK Investigational Site, Leeuwarden
GSK Investigational Site, Rotterdam
GSK Investigational Site, Bialystok
GSK Investigational Site, Bialystok
GSK Investigational Site, Krakow
GSK Investigational Site, Lodz
GSK Investigational Site, Leicester
GSK Investigational Site, Liverpool
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY